Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M98,407Revenue $M9,703Net Margin (%)30.3Z-Score19.8
Enterprise Value $M97,689EPS $12.4Operating Margin %40.8F-Score9
P/E(ttm))34.1Cash Flow Per Share $7.4Pre-tax Margin (%)40.7Higher ROA y-yY
Price/Book9.210-y EBITDA Growth Rate %26.5Quick Ratio1.7Cash flow > EarningsY
Price/Sales10.35-y EBITDA Growth Rate %25.5Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %54.7ROA % (ttm)22.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)30.2Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M235ROI % (ttm)19.7Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 419.4423%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 419.4423%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 419.4423%Reduce -84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 419.4421%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 419.4421%Reduce -58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 419.4421%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 419.4428%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 419.4428%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 419.4428%Reduce -6.62%559,700
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 419.4428%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 419.4428%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 419.4428%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 419.4428%Add 16.46%4,175
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 419.4425%New holding116,000
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 419.4425%Reduce -32.19%599,400
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 419.4425%New holding3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 419.4425%New holding7,500
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 419.4425%Add 796.27%18,266
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 419.4425%New holding6,089
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 419.4438%Reduce -39.09%884,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.20.09view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-1.52view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-5.68view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-10.83view
Rowinsky Eric KDirector 2015-03-19Sell2,333$436.14-2.88view
Rowinsky Eric KDirector 2015-03-17Sell4,667$425.45-0.44view
DiPietro KennethEVP Human Resources 2015-03-16Sell803$415.461.95view
SCANGOS GEORGE ACEO 2015-03-13Sell537$412.692.64view
SHERWIN STEPHEN ADirector 2015-03-10Sell6,000$409.673.39view
PANGIA ROBERT WDirector 2015-03-10Sell3,625$413.42.46view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
    Biogen’s Alzheimer’s Drug Shows Promising Test Results Mar 23 2015 
    Biogen Idec (BIIB) At All-time High Levels, KB Home (KBH) Revenue Growth Trajectory, Ctrip (CTRP) Re Mar 23 2015 
    The Best Upcoming Dividend Stocks Mar 20 2015 
    This Week’s Pharma Highlights Mar 19 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    February Pick Of Biotech Stocks Feb 17 2015 
    Stanley Druckenmiller's Recent Trades Feb 13 2015 
    8 Strong Recommendations for 2015 Feb 13 2015 
    Google Joins Biogen In The Fight Against Multiple Sclerosis Jan 29 2015 


    More From Other Websites
    Pfizer, Biogen, AbbVie Get Good Drug-Trial News Apr 15 2015
    Morning Movers: Delta Air Lines Soars on Earnings; Biogen Jumps on Trial Data Apr 15 2015
    Stock Futures Grapple Higher; Biogen, Akorn Lead IBD 50 List Apr 15 2015
    What We’re Trading Apr 15 2015
    Biogen Earnings Preview: 3 Key Factors to Monitor Apr 14 2015
    GoPro, Avon and Intel Highlight Tuesday's After-Hours Movers Apr 14 2015
    Tuesday's after-hours buzz: Intel, Biogen & more Apr 14 2015
    Alnylam Reports Publication of New Data on Hemophilia Drug - Analyst Blog Apr 14 2015
    4:06 pm Biogen presents new anti-LINGO-1 Phase 2 acute optic neuritis data demonstrating... Apr 14 2015
    Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair Apr 14 2015
    Biogen MS Drug Results Are 'Mildly Encouraging' In Eye Disease Test Apr 14 2015
    Aeterna Zentaris to Advance Hormone Drug to Phase III Study - Analyst Blog Apr 14 2015
    U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the... Apr 14 2015
    J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog Apr 14 2015
    Receptos Inc (RCPT), Centene Corp (CNC): Paul Sinclair Flying High With New Fund’s Top Healthcare... Apr 14 2015
    Growth In Drug Spend Is Hitting A 13-Year High. Note To Pharma: Innovation Pays. Apr 13 2015
    U.S. prescription drug spending rose 13 pct in 2014-IMS report Apr 13 2015
    U.S. prescription drug spending rose 13 pct in 2014-IMS report Apr 13 2015
    Should Biogen Be Afraid of This Upstart? Apr 13 2015
    Will Pharmaceutical Sales Drive J&J (JNJ) Earnings Again? - Analyst Blog Apr 13 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK